Using a technique developed at Vanderbilt University Medical Center, researchers identified antibodies that are excellent leads as potential therapies for human parainfluenza virus 3, a leading cause of acute and potentially fatal respiratory illness.

The Tennessee Emerging Infections Program has been awarded a new five-year grant from the Centers for Disease Control and Prevention to continue infectious disease surveillance research that has been conducted since 1999, and has expanded to include COVID, Mpox and HPV surveillance into oropharyngeal cancers.

The Vanderbilt Institute for Infection, Immunology and Inflammation recently debuted state-of-the-art new facilities in Medical Center.

The avian (bird) influenza vaccine creates a more robust immune response when paired with a potent ingredient known as an adjuvant, according to Vanderbilt research published in The Journal of Infectious Diseases.

The Vanderbilt Comprehensive Care Clinic, Nashville’s original nonprofit medical home for people living with HIV, will hold its annual Ruby Gala on Saturday, Feb. 10, 2024, at Marathon Music Works.

In a new report, members of the Southeast AIDS Education and Training Center, which is coordinated by Vanderbilt University Medical Center, offers an innovative approach to increasing the HIV workforce: train all manner of health professionals to care for people with HIV.

Vanderbilt research discovers that iron storage “spheres” inside the bacterium C. diff — the leading cause of hospital-acquired infections — are important for infection in an animal model and could offer new targets for antibacterial drugs.